Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: Results from the Framingham Heart Study

Atherosclerosis

Volumn 154, Issue 1, 2001, Pages 229-236

  McNamara, Judith R ^a,b   Shah, Paulesh K ^a   Nakajima, Katsuyuki ^c   Cupples, L Adrienne ^d   Wilson, Peter W F ^e   Ordovas, Jose M ^b   Schaefer, Ernst J ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apolipoprotein B; Cardiovascular disease; Chylomicrons; Lipoproteins; Triglycerides; Very low density lipoproteins

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL; CHYLOMICRON; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; APOLIPOPROTEINS; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS; MASSACHUSETTS; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; RISK FACTORS; SEX DISTRIBUTION; TRIGLYCERIDES;

EID: 0035177104     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00484-6     Document Type: Article

References (62)

1. High density lipoproteins as a protective factor against coronary heart disease
2. Is the level of serum triglyceride a significant predictor of coronary death in 'normotriglyceridemic' subjects?
3. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins
4. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease
5. The role of the liver in atherosclerosis
6. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events
7. Atherogenic nature of triglycerides, postprandial lipemia, and triglyceride-rich remnant lipoproteins
8. Triglycerides: A risk factor for coronary heart disease
9. Triglyceride-rich lipoproteins
10. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals: Effects of treatment with cholestyramine and gemfibrozil
11. Postprandial plasma lipoprotein changes in human subjects of different ages
12. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal
13. Role of triglyceride-rich lipoproteins from the liver and intestine in the etiology of postprandial peaks in plasma triglyceride concentration
14. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters
15. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated
16. Comparison of an immunoseparation method for direct measurement of LDL cholesterol with β-quantification (ultracentrifugation)
17. Accurate direct determination of low-density lipoprotein cholesterol using an immunoseparation reagent and enzymatic cholesterol assay
18. Sur un dosage rapide du cholesterol lie aux a- et aux B-lipoproteins du serum
19. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol
20. Quantitation of plasma lipoprotein(a) by cholesterol assay of lectin-bound lipoprotein(a)
21. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100
22. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels
23. The triglyceride issue: A view from Framingham
24. Plasma triglyceride level as a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
25. Impact of national guidelines for cholesterol risk factor screening: The Framingham offspring study
26. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
27. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
28. Remnant lipoprotein cholesterol and triglyceride: Reference ranges from the Framingham Heart Study
29. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma
30. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat
31. Characterization of human very low density lipoproteins containing two electrophoretic populations: Double prebeta lipoproteinemia and primary disbetalipoproteinemia
32. Membrane active lipids in remnant lipoproteins cause impairment of endothelial-dependent vasorelaxation
33. Reference intervals for plasma apolipoprotein A-I as determined with a commercially available immunoturbidometric assay: Results from the Framingham offspring study
34. Reference intervals for plasma apolipoprotein B as determined with a commercially available immunoturbidometric assay: Results from the Framingham offspring study
35. The effects of beta-adrenergic blocking agents on blood lipid levels
36. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein(a) abnormalities in men with premature coronary artery disease
37. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. (Adult Treatment Panel II)
38. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial
39. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study
40. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women
41. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: Results of the Framingham offspring study
42. Low density lipoprotein particle size and coronary artery disease
43. Small, dense low-density lipoprotein particles and coronary heart disease risk. A clear association with uncertain implications
44. The atherogenic role of triglycerides and small, dense low density lipoproteins: Impact of ciprofibrate therapy
45. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
46. Plasma triglyceride level and mortality from coronary heart disease
47. Triglycerides, HDL-cholesterol and coronary disease: A Framingham update on the interactions
48. Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on the 18-year risk of atherosclerotic disease
49. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study
50. Lipoprotein remnant cholesterol and triglyceride values in coronary cases and Framingham controls
51. Triglyceride concentration and ischemic heart disease: An 8-year follow-up in the Copenhagen Male Study
52. The possible role of remnant-like particles as a risk factor for sudden cardiac death
53. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
54. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death
55. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease
56. An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria
57. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay
58. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients
59. Effect of hospitalization on high-density lipoprotein cholesterol in patients undergoing elective coronary angiography
60. Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a)
61. Risk factors that attenuate the female coronary disease advantage
62. Risk factors for cardiovascular disease among women